Predicting interactome network perturbations in human cancer: application to gene fusions in acute lymphoblastic

Leon Juvenal Hajingabo1, Sarah Daakour2, Maud Martin2

  • 1Laboratoire de Bioinformatique des Génomes et des Réseaux, Université Libre de Bruxelles, B-1050 Bruxelles, Belgium.

Insights

This study reveals how gene fusions in acute lymphoblastic leukemia disrupt molecular networks. Researchers identified specific gene circuit disruptions, offering new insights into TCF3-PBX1 and ETV6-RUNX1 leukemias.

Area of Science:

  • Genomics
  • Molecular Biology
  • Bioinformatics

Background:

  • Genomic variations are linked to human diseases, serving as diagnostic and therapeutic targets.
  • Predicting the functional impact of genetic alterations on complex disease phenotypes remains challenging.
  • Chromosomal translocations are common in precursor-B-cell acute lymphoblastic leukemia (preB-ALL).

Purpose of the Study:

  • To develop an approach for extracting perturbed molecular interactions from gene expression data.
  • To investigate the functional effects of specific gene fusions in preB-ALL.
  • To gain new insights into TCF3-PBX1 and ETV6-RUNX1 leukemias.

Main Methods:

  • Utilized three chromosomal translocations (ETV6-RUNX1, BCR-ABL1, TCF3-PBX1) as models.
  • Applied a novel approach combining gene expression and interactome data analysis.
  • Extracted perturbed molecular interactions from gene expression changes.

Main Results:

  • Identified specific deregulation of MYC and JunD transcriptional circuits by ETV6-RUNX1 and TCF3-PBX1 gene fusions, respectively.
  • Discovered the bulk mRNA NXF1-dependent machinery as a direct target of the TCF3-PBX1 fusion protein.
  • Provided new molecular insights into TCF3-PBX1 and ETV6-RUNX1 acute lymphoblastic leukemia.

Conclusions:

  • The study presents a novel method for analyzing gene expression and interactome data.
  • Specific gene fusions in preB-ALL lead to distinct disruptions in transcriptional circuits.
  • Findings advance understanding of the molecular mechanisms underlying TCF3-PBX1 and ETV6-RUNX1 leukemias.

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.6K
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K